Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp.
1:16-cv-00812
Overview
Case Number
1:16-cv-00812
Filing Date
2016-09-16
Status
Litigation filed
Court
District Court, D. Delaware
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, D. Delaware
Presiding Judge
Richard Gibson Andrews
Patents Involved
There are 10 patents involved in this case.
| Application Number | Patent Number | External Links |
|---|---|---|
| - | US8604044 | |
| - | US95268449 | |
| - | US53310594 | |
| - | US4571529 | |
| - | US9604008 | |
| - | US8603044 | |
| - | US8992486 | |
| - | US8679069 | |
| - | US9526844 | |
| - | US9533105 |
Docket Entries
COMPLAINT FOR PATENT INFRINGEMENT filed against Merck Sharp & Dohme Corp. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1997492.) - filed by Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie. (Attachments: # 1 Exhibit A-H, # 2 Exhibit I-J, # 3 Civil Cover Sheet)(cna) (Entered: 09/19/2016)
2016-09-16
1
COMPLAINT FOR PATENT INFRINGEMENT filed against Merck Sharp & Dohme Corp. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1997492.) - filed by Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie. (Attachments: # 1 Exhibit A-H, # 2 Exhibit I-J, # 3 Civil Cover Sheet)(cna) (Entered: 09/19/2016)
2016-09-16
2
COMPLAINT FOR PATENT INFRINGEMENT filed against Merck Sharp & Dohme Corp. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1997492.) - filed by Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie. (Attachments: # 1 Exhibit A-H, # 2 Exhibit I-J, # 3 Civil Cover Sheet)(cna) (Entered: 09/19/2016)
2016-09-16
2
COMPLAINT FOR PATENT INFRINGEMENT filed against Merck Sharp & Dohme Corp. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1997492.) - filed by Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie. (Attachments: # 1 Exhibit A-H, # 2 Exhibit I-J, # 3 Civil Cover Sheet)(cna) (Entered: 09/19/2016)
2016-09-16
2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cna) (Entered: 09/19/2016)
2016-09-16
1
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/8/2016. Date of Expiration of Patent: 9/23/2027.Thirty Month Stay Deadline: 2/8/2019. (cna) (Entered: 09/19/2016)
2016-09-16
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,918,833; US 8,512,297; US 8,556,864; US 8,603,044; US 8,992,486. (cna) (Entered: 09/19/2016)
2016-09-16
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (cna) (Entered: 09/19/2016)
2016-09-16
1
Summons Issued with Magistrate Consent Notice attached as to Merck Sharp & Dohme Corp. on 9/16/2016. (cna)
2016-09-16
1
No Actions
SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie. Merck Sharp & Dohme Corp. served on 9/19/2016, answer due 10/11/2016. (McCann, Douglas) (Entered: 09/19/2016)
2016-09-19
1
Summons Issued
2016-09-19
1
No Actions
SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie. Merck Sharp & Dohme Corp. served on 9/20/2016, answer due 10/11/2016. (McCann, Douglas) (Entered: 09/20/2016)
2016-09-20
1
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
2016-09-21
1
No Actions
Case Assigned/Reassigned
2016-09-21
1
No Actions
ANSWER to 1 Complaint, Affirmative Defenses, and COUNTERCLAIMS against Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC by Merck Sharp & Dohme Corp..(Connolly, Arthur) Modified on 10/12/2016 (nms). (Entered: 10/11/2016)
2016-10-11
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Entered: 10/11/2016)
2016-10-11
1
Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 10/27/2016, at 11:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 10/14/2016. (nms) (Entered: 10/14/2016)
2016-10-14
1
NOTICE of Appearance by Ronald P. Golden, III on behalf of All Plaintiffs (Golden, Ronald) (Entered: 10/14/2016)
2016-10-14
1
PROPOSED Scheduling Order, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Letter)(Golden, Ronald) Modified on 10/25/2016 (nms). (Entered: 10/25/2016)
2016-10-25
1
PROPOSED Scheduling Order, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Letter)(Golden, Ronald) Modified on 10/25/2016 (nms). (Entered: 10/25/2016)
2016-10-25
2
MOTION for Pro Hac Vice Appearance of Attorney Juanita Brooks, Brian D. Coggio, Matt Colvin, Sarah M. Cork, Ahmed J. Davis, John S. Goetz, and Min Woo Park - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (McCann, Douglas) (Entered: 10/26/2016)
2016-10-26
1
SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney Juanita Brooks, Brian D. Coggio, Matt Colvin, Sarah M. Cork, Ahmed J. Davis, John S. Goetz, and Min Woo Park, filed by Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 10/27/2016. (nms)
2016-10-27
1
No Actions
Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference was held on 10/27/2016. Counsel present for Plaintiffs: R. Golden, J. Goetz, A. Davis, and S. Donahue. Counsel present for Defendants: R. Nimrod, G. Bonefield, A. Connolly, R. Yure. Plaintiffs' counsel will resubmit a final scheduling order for approval, which shall include the dates discussed. (Court Reporter Leonard Dibbs.) (nms)
2016-10-27
1
No Actions
SO ORDERED
2016-10-27
1
No Actions
Scheduling Conference
2016-10-27
1
No Actions
Official Transcript of Scheduling Conference held on 10-27-16 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/18/2016. Redacted Transcript Deadline set for 11/28/2016. Release of Transcript Restriction set for 1/26/2017. (lad) (Entered: 10/28/2016)
2016-10-28
1
Pro Hac Vice Attorney Brian D. Coggio for Sanofi Winthrop Industrie,Brian D. Coggio for Sanofi-Aventis Deutschland GmbH,Brian D. Coggio for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2016-11-02
1
No Actions
Pro Hac Vice Attorney John Goetz for Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH,and for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2016-11-02
1
No Actions
Pro Hac Vice Attorney Juanita Brooks for Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH,and for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2016-11-02
1
No Actions
Pro Hac Vice Attorney Matt Colvin for Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, and for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2016-11-02
1
No Actions
Pro Hac Vice Attorney Min Woo Park,Sarah Cork for Sanofi Winthrop Industrie,Sanofi-Aventis Deutschland GmbH,and for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2016-11-02
1
No Actions
Add Attorneys - PHV only
2016-11-02
1
No Actions
Add Attorneys - PHV only
2016-11-02
1
No Actions
Add Attorneys - PHV only
2016-11-02
1
No Actions
Add Attorneys - PHV only
2016-11-02
1
No Actions
Add Attorneys - PHV only
2016-11-02
1
No Actions
ANSWER to 8 Answer to Complaint, Counterclaim by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 11/04/2016)
2016-11-04
1
Pro Hac Vice Attorney Ahmed J. Davis for Sanofi Winthrop Industrie,Sanofi-Aventis Deutschland GmbH, and for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2016-11-04
1
No Actions
Add Attorneys - PHV only
2016-11-04
1
No Actions
PROPOSED Scheduling Order, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 11/10/2016 (nms). (Entered: 11/10/2016)
2016-11-10
1
SCHEDULING ORDER: Discovery Matters and Disputes Relating to Protective Orders are referred to Chief Magistrate Judge Mary Pat Thynge. Joinder of Parties due by 8/1/2017. Amended Pleadings due by 8/1/2017. Fact Discovery relating to licensing and exhaustion due by 4/28/2017. Fact Discovery related to infringement and invalidity shall be completed by 10/27/2017. Dispositive Motions due by 10/2/2017. Joint Claim Construction Brief due by 6/29/2017. A Markman Hearing is set for 8/21/2017, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A Pretrial Conference is set for 5/18/2018, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews. A Bench Trial is set to begin on 5/29/2018, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 11/10/2016. (nms) Modified on 7/27/2017 (nms). (Entered: 11/10/2016)
2016-11-10
1
NOTICE OF SERVICE of First Requests for Admission, First Interrogatories and First Requests for Production filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 11/18/2016)
2016-11-18
1
NOTICE OF SERVICE of Defendant's First Set of Requests for Production of Documents and First Set of Interrogatories to Plaintiff filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 11/18/2016)
2016-11-18
1
STIPULATION to Extend Time to file Paragraph 3 Disclosures and Initial Disclosures to 12/9/16 and Protective Order to 12/5/16 - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 11/28/2016 (nms). (Entered: 11/23/2016)
2016-11-23
1
CORRECTING ENTRY: The docket text for D.I. 20 has been corrected to reflect the filing is a stipulation. The stipulation filing event code should be used for future filings similar to this. (nms)
2016-11-28
1
No Actions
SO ORDERED, re 20 STIPULATION to Extend Time to file Paragraph 3 Disclosures and Initial Disclosures to 12/9/16, and Protective Order to 12/5/16, filed by Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 11/28/2016. (nms)
2016-11-28
1
No Actions
- CORRECTING ENTRY
2016-11-28
1
No Actions
SO ORDERED
2016-11-28
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney D. Michael Underhill, William D. Marsillo, Bill Ward, Ph.D., Joseph E. Lasher, Jon R. Knight, and Alex T. Potter of Boies, Schiller & Flexner LLP - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 12/1/2016 (nms). (Entered: 11/30/2016)
2016-11-30
1
SO ORDERED, re 21 MOTION for Pro Hac Vice Appearance of Attorney D. Michael Underhill, William D. Marsillo, Bill Ward, Ph.D., Joseph E. Lasher, Jon R. Knight, and Alex T. Potter of Boies, Schiller & Flexner LLP, filed by Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 12/1/2016. (nms)
2016-12-01
1
No Actions
SO ORDERED
2016-12-01
1
No Actions
STIPULATION TO EXTEND TIME to file Joint Proposed Protective Order to December 9, 2016 - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 12/05/2016)
2016-12-05
1
SO ORDERED, re 22 STIPULATION TO EXTEND TIME to file Joint Proposed Protective Order to December 9, 2016, filed by Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 12/5/2016. (nms)
2016-12-05
1
No Actions
SO ORDERED
2016-12-05
1
No Actions
PROPOSED Stipulated Protective Order, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 12/9/2016 (nms). (Entered: 12/09/2016)
2016-12-09
1
NOTICE OF SERVICE of Rule 26 and Para. 3 Disclosures filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 12/09/2016)
2016-12-09
1
NOTICE OF SERVICE of Rule 26 and Paragraph 3(a)-(c) Disclosures filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 12/09/2016)
2016-12-09
1
SO ORDERED Granting 23 Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 12/12/2016. (nms) (Entered: 12/12/2016)
2016-12-12
1
NOTICE of Change of Address by Ronald P. Golden, III (Golden, Ronald) (Entered: 12/14/2016)
2016-12-14
1
NOTICE OF SERVICE of Defendant's Objections and Responses to Plaintiffs' First Set of Requests for Admission, Defendant's Objections and Responses to Plaintiffs' First Set of Interrogatories and Defendant's Objections and Responses to Plaintiffs' First Requests for Production of Documents filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 12/23/2016)
2016-12-23
1
NOTICE OF SERVICE of Objections and Responses to First Set of Requests for Production and First Set of Interrogatories filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 12/28/2016)
2016-12-28
1
NOTICE Of Service of Merck Sharp & Dohme's Second Set of Interrogatories to Plaintiffs, filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) Modified on 1/3/2017 (nms). (Entered: 12/30/2016)
2016-12-30
1
MOTION for Pro Hac Vice Appearance of Attorney Raymond N. Nimrod, Gregory D. Bonifield, and John P. Galanek - filed by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Entered: 01/06/2017)
2017-01-06
1
SO ORDERED, re 31 MOTION for Pro Hac Vice Appearance of Attorney Raymond N. Nimrod, Gregory D. Bonifield, and John P. Galanek, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 1/6/2017. (nms)
2017-01-06
1
No Actions
SO ORDERED
2017-01-06
1
No Actions
NOTICE OF SERVICE of Second Set of Requests for Production of Documents and Third Set of Interrogatories filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 01/13/2017)
2017-01-13
1
NOTICE OF SERVICE of (1) Plaintiffs' Second set of Requests for Production (Nos. 13-93); and (2) Plaintffs; Second set of Interrogatories to Defendants (Nos. 7-16) filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 01/17/2017)
2017-01-17
1
MOTION for Pro Hac Vice Appearance of Attorney Amanda K. Antons, Ph.D. - filed by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Entered: 01/26/2017)
2017-01-26
1
SO ORDERED, re 34 MOTION for Pro Hac Vice Appearance of Attorney Amanda K. Antons, Ph.D., filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 1/27/2017. (nms)
2017-01-27
1
No Actions
Pro Hac Vice Attorney Amanda K. Antons for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-01-27
1
No Actions
SO ORDERED
2017-01-27
1
No Actions
Add Attorneys - PHV only
2017-01-27
1
No Actions
NOTICE OF SERVICE of Plaintiffs' Paragraph 4(c) Disclosure of Initial Claim Charts filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 02/06/2017)
2017-02-06
1
NOTICE OF SERVICE of Objections and Responses to Merck Sharp & Dohme's Second Set of Interrogatories filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 02/06/2017)
2017-02-06
1
NOTICE OF SERVICE of (1) Objections and Responses to Third Set of Interrogatories (Nos. 7-14) and (2) Objections and Responses to Second Set of Requests for Production (Nos. 31-102) filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 02/21/2017)
2017-02-21
1
NOTICE OF SERVICE of Objections and Responses to Plaintiffs' Second Set of Requests for Production of Documents (Nos. 13-93) and Objections and Responses to Plaintiffs' Second Set of Interrogatotories to Defendant (Nos. 7-16) filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 02/24/2017)
2017-02-24
1
NOTICE OF SERVICE of Merck Sharp & Dohme Corp.'s First Set of Requests for Admission to Plaintiffs and Third Set of Requests for Production of Documents filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 02/28/2017)
2017-02-28
1
NOTICE OF SERVICE of Merck Sharp & Dohme's Initial Invalidity Contentions of U.S. Patent Nos. 8,604,044, 8,679,069, 8,992,486, 7,476,652 & 7,713,930 filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 03/15/2017)
2017-03-15
1
NOTICE OF SERVICE of 30(b)(6) Notice of Deposition of Merck Sharp & Dohme Corporation filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 03/15/2017)
2017-03-15
1
NOTICE OF SERVICE of Plaintiffs' Third Set of Requests For Production (No. 94) filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 03/20/2017)
2017-03-20
1
NOTICE OF SERVICE of (1) Amended Notice of Deposition of Anja Liehr-Martin Pursuant to Federal Rule of Civil Procedure 30(b)(1), (2) Amended Notice of Deposition of Paul Jansen Pursuant to Federal Rule of Civil Procedure 30(b)(1), and (3) Notice of Deposition of Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GMBH, and Sanofi Winthrop Industrie Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 03/23/2017)
2017-03-23
1
STIPULATION and Proposed Order Regarding Extending Certain Deadlines - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 3/24/2017 (nms). (Entered: 03/23/2017)
2017-03-23
1
NOTICE to Take Deposition of Alicia Dix on April 18, 2017 filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 03/24/2017)
2017-03-24
1
NOTICE to Take Deposition of Jeffrey Givand on April 17, 2017 filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 03/24/2017)
2017-03-24
1
NOTICE to Take Deposition of Richard Tarburton on April 19, 2017 filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 03/24/2017)
2017-03-24
1
SO ORDERED, re 44 STIPULATION and Proposed Order Regarding Extending Certain Deadlines. Signed by Judge Richard G. Andrews on 3/24/2017. (nms)
2017-03-24
1
No Actions
SO ORDERED
2017-03-24
1
No Actions
NOTICE OF SERVICE of Testimony and Production Subpoena directed to Ypsomed AG filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 03/27/2017)
2017-03-27
1
NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Admission to Defendant (Nos. 13-39) and (2) Plaintiffs' Third Set of Interrogatories to Defendant (Nos. 17-20) filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 03/29/2017)
2017-03-29
1
NOTICE OF SERVICE of Plaintiffs' Subpoena to Produce Documents, Information, or Objects or to Permit Inspection of Premises in a Civil Action Directed to Ypsomed, AG filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 03/29/2017)
2017-03-29
1
STIPULATION TO EXTEND TIME for Claim Construction Issue Identification to April 5, 2017 - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 03/30/2017)
2017-03-30
1
NOTICE OF SERVICE of Objections and Responses to Third Set of Requests for Production of Documents (Nos. 103-112) filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 03/31/2017)
2017-03-31
1
NOTICE OF SERVICE of Responses and Objections to 30(b)(6) Notice filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 04/03/2017)
2017-04-03
1
SO ORDERED, re 51 STIPULATION TO EXTEND TIME for Claim Construction Issue Identification to April 5, 2017. Signed by Judge Richard G. Andrews on 4/3/2017. (nms)
2017-04-03
1
No Actions
SO ORDERED
2017-04-03
1
No Actions
Unopposed MOTION for Leave to File A First Amended And Supplemental Complaint For Patent Infringement - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order, # 2 Exhibit 1, # 3 Exhibit 2)(Golden, Ronald) Modified on 4/5/2017 (nms). (Entered: 04/04/2017)
2017-04-04
1
Joint MOTION and Proposed Order to Alter Claim Construction Deadlines - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 4/5/2017 (nms). (Main Document 55 replaced on 4/5/2017) (nms). (Entered: 04/04/2017)
2017-04-04
1
ORDER Granting 55 Joint MOTION and Proposed Order to Alter Claim Construction Deadlines (*Reset Deadlines/Hearings: Joint Claim Construction Brief due by 8/21/2017, a Markman Hearing is now reset for 9/20/2017, at 9:00 AM in Courtroom 6A) (see Stipulation for further details). Signed by Judge Richard G. Andrews on 4/5/2017. (nms) (Entered: 04/05/2017)
2017-04-05
1
ORDER Granting 54 Unopposed MOTION for Leave to File A First Amended And Supplemental Complaint For Patent Infringement. Signed by Judge Richard G. Andrews on 4/5/2017. (nms) (Entered: 04/05/2017)
2017-04-05
1
FIRST AMENDED And Supplemental Complaint For Patent Infringement against Merck Sharp & Dohme Corp.- filed by Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC, Sanofi Winthrop Industrie.(nms) (Entered: 04/05/2017)
2017-04-05
1
CORRECTING ENTRY: The pdf for D.I. 55 has been replaced per counsel's request. A correction to one of the dates listed has been corrected. (nms)
2017-04-05
1
No Actions
- CORRECTING ENTRY
2017-04-05
1
No Actions
NOTICE OF SERVICE of Notice of Deposition of Elmar Wein Pursuant to Federal Rule of Civil Procedure 30(b)(1) filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 04/10/2017)
2017-04-10
1
NOTICE OF SERVICE of Objections and Responses to Defendants First Set of Requests for Admission (Nos. 1-28) filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 04/10/2017)
2017-04-10
1
NOTICE OF SERVICE of Deposition Subpoenas directed to Dr. Beat Maurer and Simon Michel filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 04/10/2017)
2017-04-10
1
NOTICE OF SERVICE of Paragraph 4(c) Disclosure of Initial Claim Charts for Newly Asserted Claims filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 04/12/2017)
2017-04-12
1
Pro Hac Vice Attorney John Galanek for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2017-04-12
1
No Actions
Add Attorneys - PHV only
2017-04-12
1
No Actions
Pro Hac Vice Attorney Jon R. Knight and Alex T. Potter for Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, and Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
2017-04-17
1
No Actions
Add Attorneys - PHV only
2017-04-17
1
No Actions
NOTICE OF SERVICE of document production MSDSAN1732204-1742237 filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 04/18/2017)
2017-04-18
1
NOTICE OF SERVICE of Merck Sharp & Dohme's Objections and Responses to Plaintiffs' 30(b)(6) Notice filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 04/19/2017)
2017-04-19
1
ANSWER to 58 First Amended and Supplemental Complaint, Affirmative Defenses, and COUNTERCLAIMS against Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC, by Merck Sharp & Dohme Corp..(Connolly, Arthur) Modified on 4/20/2017 (nms). (Entered: 04/19/2017)
2017-04-19
1
NOTICE OF SERVICE of Merck Sharp & Dohme's Objections and Responses to Plaintiffs' Third Set of Requests for Production (No. 94) filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 04/20/2017)
2017-04-20
1
NOTICE to Take Deposition of Phil Green on May 12, 2017 filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 04/28/2017)
2017-04-28
1
NOTICE OF SERVICE of Deposition Testimony Subpoena Directed to Jacob Lange, Ypsomed AG filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 04/28/2017)
2017-04-28
1
STIPULATION and Proposed Order Regarding Extending Discovery Deadlines - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 5/3/2017 (nms). (Entered: 05/02/2017)
2017-05-02
1
SO ORDERED, re 69 STIPULATION and Proposed Order Regarding Extending Discovery Deadlines. Signed by Judge Richard G. Andrews on 5/3/2017. (nms) (Entered: 05/03/2017)
2017-05-03
1
CORRECTING ENTRY: The docket text for D.I. 69 has been corrected to reflect the filing is a Stipulation and not a motion. (nms)
2017-05-03
1
No Actions
- CORRECTING ENTRY
2017-05-03
1
No Actions
NOTICE OF SERVICE of (1) Sanofis First Supplemental Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information (ESI); and (2) Plaintiffs First Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (e) filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 05/04/2017)
2017-05-04
1
NOTICE of Change of Address for Ahmed J. Davis, Min Woo Park and Sara M. Cork by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC (Golden, Ronald) (Entered: 05/04/2017)
2017-05-04
1
NOTICE OF SERVICE of Merck Sharp & Dohme's Objections and Responses to Plaintiffs' Second Set of Requests for Admission to Defendant and Merck Sharp & Dohme's Objections and Responses to Plaintiffs' Third Set of Interrogatories to Defendant filed by Merck Sharp & Dohme Corp..(Newell, Ryan) (Entered: 05/05/2017)
2017-05-05
1
ANSWER to 65 Answer to Amended Complaint, and Counterclaims, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) Modified on 5/11/2017 (nms). (Entered: 05/10/2017)
2017-05-10
1
ORAL ORDER: A Telephone Conference regarding discovery matters briefly addressed on May 18, 2017 has been scheduled for Thursday, May 25,2017 at 05:00 pm Eastern to be initiated by counsel for the plaintiffs. Until the issues of D.I. #56 and D.I. #69 are resolved, the deadline of May 19, 2017 in both orders is held in abeyance. Counsel for plaintiff shall arrange the services of a court reporter.. Issued by Judge Mary Pat Thynge on 5/18/17. (kjk) (Entered: 05/18/2017)
2017-05-18
1
~Util - Set Hearings AND Oral Order
2017-05-18
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Brian P. Biddinger - filed by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Entered: 05/22/2017)
2017-05-22
1
Letter to Chief Magistrate Judge Mary Pat Thynge from Ronald P. Golden III regarding request to extend discovery deadlines. (Attachments: # 1 Proposed Order, # 2 Proposed Order)(Golden, Ronald) Modified on 5/23/2017 (nms). (Entered: 05/22/2017)
2017-05-22
1
SO ORDERED
2017-05-22
1
No Actions
SO ORDERED, re 76 MOTION for Pro Hac Vice Appearance of Attorney Brian P. Biddinger, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 5/22/2017. (nms)
2017-05-22
1
No Actions
[SEALED] Letter to Chief Magistrate Judge Mary Pat Thynge from Arthur G. Connolly, III responding to Sanofi's May 22, 2017 letter. (Attachments: # 1 Exhibit A, # 2 Proposed Order, # 3 Certificate of Service)(Connolly, Arthur) Modified on 5/24/2017 (nms). (Entered: 05/23/2017)
2017-05-23
1
- CORRECTING ENTRY
2017-05-23
1
No Actions
CORRECTING ENTRY: D.I. 77 has been placed under seal. (nms)
2017-05-23
1
No Actions
Add Attorneys - PHV only
2017-05-25
1
No Actions
Pro Hac Vice Attorney Brian P. Biddinger for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-05-25
1
No Actions
REDACTED VERSION of 78 Letter, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order, # 2 Proposed Order)(Golden, Ronald) Modified on 5/30/2017 (nms). (Entered: 05/30/2017)
2017-05-30
1
NOTICE OF SERVICE of Initial Invalidity Contentions of U.S. Patent Nos. 9,526,844,9,533,105,94,457,152,9,485,587,9592,348 filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 05/30/2017)
2017-05-30
1
REDACTED VERSION of 78 Letter, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Entered: 05/30/2017)
2017-05-30
1
STIPULATION and Order Extending Time - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 6/5/2017 (nms). (Entered: 06/05/2017)
2017-06-05
1
SO ORDERED, re 82 STIPULAITON and Order Extending Time (*Reset Deadlines: Joint Claim Construction Brief due by 8/28/2017) (see Stipulation for further dates). Signed by Judge Richard G. Andrews on 6/5/2017. (nms) (Entered: 06/06/2017)
2017-06-06
1
MOTION for Pro Hac Vice Appearance of Attorney Martin Ellison - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 06/08/2017)
2017-06-08
1
SO ORDERED
2017-06-08
1
No Actions
SO ORDERED, re 84 MOTION for Pro Hac Vice Appearance of Attorney Martin Ellison, filed by Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 6/8/2017. (nms)
2017-06-08
1
No Actions
STIPULATION Extend deadline for parties to submit Joint Claim Construction Chart by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 06/12/2017)
2017-06-12
1
SO ORDERED
2017-06-13
1
No Actions
SO ORDERED, re 85 Stipulation and Order (*Joint Claim Construction Chart due by 6/16/2017). Signed by Judge Richard G. Andrews on 6/13/2017. (nms)
2017-06-13
1
No Actions
Add Attorneys - PHV only
2017-06-14
1
No Actions
Pro Hac Vice Attorney Martin Ellison for Sanofi Winthrop Industrie,Martin Ellison for Sanofi-Aventis Deutschland GmbH,Martin Ellison for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2017-06-14
1
No Actions
JOINT Claim Construction Chart, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 1)(Golden, Ronald) Modified on 6/19/2017 (nms). (Entered: 06/16/2017)
2017-06-16
1
EXHIBITS to 86 Joint Claim Construction Chart, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit A-1, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit C-1, # 6 Exhibit D, # 7 Exhibit D-1, # 8 Exhibit E, # 9 Exhibit E-1, # 10 Exhibit F, # 11 Exhibit F-1, # 12 Exhibit G, # 13 Exhibit H, # 14 Exhibit H-1, # 15 Exhibit I, # 16 Exhibit I-1, # 17 Exhibit J, # 18 Exhibit J-1, # 19 Exhibit K, # 20 Exhibit K-1)(Golden, Ronald) Modified on 6/19/2017 (nms). (Entered: 06/16/2017)
2017-06-16
1
Letter to Honorable Richard G. Andrews from Ronald P. Golden III regarding Inter Partes Review petitions filed for '652 and '930 patents. (Golden, Ronald) (Entered: 06/19/2017)
2017-06-19
1
NOTICE OF SERVICE of Plaintiffs' Third Set of Request for Admission to Defendant (No. 40) filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 06/21/2017)
2017-06-21
1
Unopposed MOTION for Leave to File a Second Amended and Supplemental Complaint for Patent Infringement and to Amend Scheduling Order - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order, # 2 Exhibit 1, # 3 Exhibit 2)(Golden, Ronald) Modified on 6/26/2017 (nms). (Entered: 06/26/2017)
2017-06-26
1
NOTICE OF SERVICE of Plaintiffs' Paragraph 4(c) Disclosure of Inital Claim Charts for the '008 Patent filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 06/27/2017)
2017-06-27
1
ORDER Granting 90 Unopposed MOTION for Leave to File a Second Amended and Supplemental Complaint for Patent Infringement and to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/28/2017. (nms) (Entered: 06/28/2017)
2017-06-28
1
SECOND AMENDED and Supplemental Complaint for Patent Infringement against Merck Sharp & Dohme Corp.- filed by Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC, Sanofi Winthrop Industrie.(nms) (Entered: 06/28/2017)
2017-06-28
1
NOTICE of Appearance by AnnaMartina Tyreus Hufnal on behalf of All Plaintiffs (Hufnal, AnnaMartina) (Entered: 06/30/2017)
2017-06-30
1
Remark
2017-07-06
1
No Actions
Remark: Counsel is reminded to submit a new Report to the Commissioner of Patent and Trademarks in light of the Second Amended Complaint filed at D.I. 93 . (nms)
2017-07-06
1
No Actions
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,457,152; US 9,486,587; US 9,526,844; US 9,533,105; US 9,592,348; US 9,604,008; . (Golden, Ronald) (Entered: 07/11/2017)
2017-07-11
1
NOTICE of Appearance by Ryan Patrick Newell on behalf of Merck Sharp & Dohme Corp. (Newell, Ryan) (Entered: 07/11/2017)
2017-07-11
1
NOTICE of Appearance by Mary I. Akhimien on behalf of Merck Sharp & Dohme Corp. (Akhimien, Mary) (Entered: 07/11/2017)
2017-07-11
1
Letter to Honorable Richard G. Andrews from Ronald P. Golden III regarding Expedited consideration of discovery/scheduling issue regarding Ypsomed. (Golden, Ronald) (Additional attachment(s) added on 7/12/2017: # 1 Exhibit A) (nms). (Entered: 07/11/2017)
2017-07-11
1
ANSWER to 93 Second Amended Complaint, Affirmative Defenses and, COUNTERCLAIM against Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC, by Merck Sharp & Dohme Corp..(Connolly, Arthur) Modified on 7/13/2017 (nms). (Entered: 07/12/2017)
2017-07-12
1
- CORRECTING ENTRY
2017-07-12
1
No Actions
Telephone Conference
2017-07-12
1
No Actions
CORRECTING ENTRY: Per counsel's request Exhibit A has been added to the letter filed at D.I. 98 . The exhibit was inadvertently omitted in the first instance. The NEF has been regenerated. (nms)
2017-07-12
1
No Actions
Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Conference held on 7/12/2017, regarding the Letter filed at D.I. 98 . Counsel present for Plaintiffs: R. Golden, M. Underhill, and J. Goetz. Counsel present for Defendants: A. Connolly, G. Bonefield, B. Didenger, K. Farnan, and J. Holderith. Plaintiffs' request (D.I. 98 ) is DENIED. The deposition shall go forward. (Court Reporter Kevin Maurer.) (nms)
2017-07-12
1
No Actions
Official Transcript of Discovery TC held on 07 12 17 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 8/4/2017. Redacted Transcript Deadline set for 8/14/2017. Release of Transcript Restriction set for 10/12/2017. (kjm) (Entered: 07/14/2017)
2017-07-14
1
NOTICE OF SERVICE of Second Supplemental Invalidity Contentions of U.S. Patent No. 9,604,008, filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) Modified on 7/18/2017 (nms). (Entered: 07/17/2017)
2017-07-17
1
NOTICE OF SERVICE of Objections and Responses to Plaintiffs' Third Set of Requests for Admission to Defendant filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 07/21/2017)
2017-07-21
1
NOTICE OF SERVICE of (1) Plaintiffs Second Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(A)(1) and (E); (2) Sanofis Second Supplemental Disclosures Pursuant to Paragraph 3 of the Default Standard For Discovery, Including Discovery of Electronically Stored Information (ESI); (3) Plaintiffs First Supplemental Objections and Responses to Defendants First Set of Requests for Admission; (4) Plaintiffs First Supplemental Objections and Responses to Merck Sharp & Dohmes Second Set of Interrogatories; and (5) Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GMBH, and Sanofi Winthrop Industries First Supplemental Objections and Responses to Merck Sharp & Dohmes First Set of Interrogatories filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 07/21/2017)
2017-07-21
1
NOTICE requesting Clerk to remove Juanita Brooks as co-counsel. Reason for request: no longer working on case. (Golden, Ronald) (Entered: 07/24/2017)
2017-07-24
1
ANSWER to 99 Answer to Amended Complaint, and Counterclaims, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) Modified on 7/27/2017 (nms). (Entered: 07/26/2017)
2017-07-26
1
ORAL ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 8/1/2017 at 2:00 PM Eastern Time before Chief Magistrate Judge Mary Pat Thynge to discuss a discovery issue. The submissions of the parties shall be provided to Judge Thynge as previously directed during the 7/26/17 call. Ordered by Judge Mary Pat Thynge on 7/27/17. (cak) (Entered: 07/27/2017)
2017-07-27
1
[SEALED] Letter to Chief Magistrate Judge Mary Pat Thynge from Ronald P. Golden III, regarding discovery dispute (see Order at D.I. 106 ). (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Golden, Ronald) Modified on 7/28/2017 (nms). (Entered: 07/27/2017)
2017-07-27
1
Order Setting Teleconference
2017-07-27
1
No Actions
Case Referred to Magistrate Judge
2017-07-27
1
No Actions
Case Referred to Magistrate Judge
2017-07-27
1
No Actions
Per D.I. 17 Discovery Matters and Disputes Relating to Protective Orders are REFERRED to Magistrate Judge Mary Pat Thynge. (nms)
2017-07-27
1
No Actions
CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for discovery issues per DI 17. Should any discovery issues arise, counsel shall follow the procedures found on Judge Thynge's Forms Section of the Court web page under "Discovery Dispute Procedures." (cak) Modified on 7/27/2017 (cak).
2017-07-27
1
No Actions
[SEALED] Letter to Chief Magistrate Judge Mary Pat Thynge from Arthur G. Connolly, III, response to Sanofi's July 27, 2017 (D.I. 107 . (Attachments: # 1 Exhibits 1-4, # 2 Certificate of Service)(Connolly, Arthur) Modified on 7/31/2017 (nms). (Entered: 07/31/2017)
2017-07-31
1
Telephone Conference
2017-08-01
1
No Actions
Minute Entry for proceedings held before Judge Mary Pat Thynge - Telephone Conference re: discovery dispute held on 8/1/2017; The transcript shall serve as the order of the court. ATTENDEES: Pltff. - R. Golden, III, Esq., J.Goetz, M. Underhill, Esq.; DEFT. - A. Connolly, III, Esq., A. Antons, Esq., G. Bonefield, Esq; CLERK - Kincaid. (Court Reporter Stacey Vickers.) (kjk)
2017-08-01
1
No Actions
ORAL ORDER: The Court having held a teleconference with counsel to address the discovery issues contained in the parties submissions ( D.I. 107, 108 ), IT IS ORDERED that the transcript of the discussions and rulings during the teleconference of August 1, 2017, shall serve as the Order of the Court in this matter.. Issued by Judge Mary Pat Thynge on 8/2/17. (kjk) (Entered: 08/02/2017)
2017-08-02
1
PROPOSED Order regarding License/Exhaustion Schedule, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 8/2/2017 (nms). (Entered: 08/02/2017)
2017-08-02
1
Oral Order
2017-08-02
1
No Actions
ORDER re 110 GRANTING Proposed Order to Amend the Scheduling Order ( D.I. 17) as set during the August 1, 2017 telephone conference filed by Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi-Aventis U.S. LLC. ( SEE ORDER FOR DETAILS ). Signed by Judge Mary Pat Thynge on 8/3/17. (kjk) (Entered: 08/03/2017)
2017-08-03
1
REDACTED VERSION of 107 Letter,by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibits A-D)(Golden, Ronald) Modified on 8/8/2017 (nms). (Entered: 08/03/2017)
2017-08-03
1
NOTICE of Change of Address by Arthur G. Connolly, III (Connolly, Arthur) (Entered: 08/04/2017)
2017-08-04
1
REDACTED VERSION of 108 Letter, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibits 1-4)(Connolly, Arthur) Modified on 8/8/2017 (nms). (Entered: 08/07/2017)
2017-08-07
1
STIPULATION and Order to extend claim construction deadlines - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 8/9/2017 (nms). (Entered: 08/09/2017)
2017-08-09
1
SO ORDERED
2017-08-10
1
No Actions
SO ORDERED, re 115 STIPULATION and Order to extend claim construction deadlines. Signed by Judge Richard G. Andrews on 8/10/2017. (nms)
2017-08-10
1
No Actions
[SEALED] Letter to Chief Magistrate Judge Mary Pat Thynge from Ronald P. Golden III regarding Ypsomed discovery. (Attachments: # 1 Exhibit A-D)(Golden, Ronald) (Entered: 08/25/2017)
2017-08-25
1
[SEALED] Letter to Chief Magistrate Judge Mary Pat Thynge from Arthur G. Connolly, III regarding In response to Sanofi's August 25, 2017 Letter - re 116 Letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Certificate of Service)(Connolly, Arthur) (Entered: 08/28/2017)
2017-08-28
1
APPENDIX to 119 Joint Claim Construction Brief, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 8/29/2017 (nms). (Entered: 08/28/2017)
2017-08-28
1
[SEALED] Joint Claim Construction Brief, filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 8/29/2017 (nms). (Entered: 08/28/2017)
2017-08-28
1
[SEALED] Letter to the Honorable Mary Pat Thynge from Ronald P. Golden III, regarding exhibits to 116 Letter. (Attachments: # 1 Exhibit E, # 2 Exhibit F)(Golden, Ronald) Modified on 8/30/2017 (nms). (Entered: 08/29/2017)
2017-08-29
1
[SEALED] Letter to The Honorable Mary Pat Thynge from Kelly E. Farnan regarding response to Plaintiff's letter of August 25, 2017 regarding Ypsomed Discovery - re 116 Letter. (Attachments: # 1 Exhibit 1-6)(Farnan, Kelly) (Entered: 08/30/2017)
2017-08-30
1
Minute Entry for proceedings held before Judge Mary Pat Thynge: Telephone Conference re: discovery dispute held on 8/31/2017; The transcript shall serve as the order of the court. ATTENDEES: PLTFF. - R. Golden, III, Esq.; M. Underhill, Esq.; J. Goetz, Esq.; DEFT. - A. Connolly, Esq.; B. Biddinger, Esq.; ( Court Reporter - Taneyah Carroll ). (kjk)
2017-08-31
1
No Actions
REDACTED VERSION of 116 Letter by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A-D)(Golden, Ronald) (Entered: 09/01/2017)
2017-09-01
1
REDACTED VERSION of 117 Letter, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibits 1-3)(Connolly, Arthur) Modified on 9/5/2017 (nms). (Entered: 09/05/2017)
2017-09-05
1
REDACTED VERSION of 119 Joint Claim Construction Brief, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 9/5/2017 (nms). (Entered: 09/05/2017)
2017-09-05
1
REDACTED VERSION of 121 Letter, by Ypsomed AG. (Attachments: # 1 Exhibits 1-6)(Farnan, Kelly) Modified on 9/7/2017 (nms). (Entered: 09/06/2017)
2017-09-06
1
REDACTED VERSION of 120 Letter, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibits E-F)(Golden, Ronald) Modified on 9/8/2017 (nms). (Entered: 09/08/2017)
2017-09-08
1
[SEALED] Joint Amended Claim Construction Brief, filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 9/8/2017 (nms). (Entered: 09/08/2017)
2017-09-08
1
Telephone Conference
2017-09-08
1
No Actions
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 120 . (nms)
2017-09-08
1
No Actions
Deficiency re Redacted Documents
2017-09-08
1
No Actions
Letter to Honorable Richard G. Andrews from Ronald P. Golden III regarding redline of Joint Amended Claim Construction Brief. (Golden, Ronald) (Entered: 09/11/2017)
2017-09-11
1
[SEALED] EXHIBIT to 128 Letter, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 9/11/2017 (nms). (Entered: 09/11/2017)
2017-09-11
1
NOTICE to Take Deposition of Merck Sharp & Dohme 30(b)(6) on October 13, 2017 filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 09/11/2017)
2017-09-11
1
Letter to The Honorable Mary Pat Thynge, from Ronald P. Golden III, regarding license/Exhaustion schedule. (Attachments: # 1 Proposed Order, # 2 Exhibit 1)(Golden, Ronald) Modified on 9/12/2017 (nms). (Entered: 09/11/2017)
2017-09-11
1
CORRECTING ENTRY: The docket text for D.I. 131 has been corrected to reflect the letter is to the Honorable Mary Pat Thynge. (nms)
2017-09-12
1
No Actions
- CORRECTING ENTRY
2017-09-12
1
No Actions
Letter to Chief Magistrate Judge Mary Pat Thynge from Arthur G. Connolly, III regarding response to Sanofi's letter of September 11, 2017 (D.I. 131 ). (Connolly, Arthur) Modified on 9/14/2017 (nms). (Entered: 09/13/2017)
2017-09-13
1
MOTION for Pro Hac Vice Appearance of Attorney Matthew A. Traupman - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Certification of Matthew A. Traupman, # 2 Proposed Order)(Connolly, Arthur) (Entered: 09/15/2017)
2017-09-15
1
REDACTED VERSION of 127 Amended Joint Claim Construction Brief, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 9/18/2017 (nms). (Entered: 09/15/2017)
2017-09-15
1
REDACTED VERSION of 129 Exhibit, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 9/18/2017 (nms). (Entered: 09/15/2017)
2017-09-15
1
SO ORDERED, re 133 MOTION for Pro Hac Vice Appearance of Attorney Matthew A. Traupman, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/15/2017. (nms)
2017-09-15
1
No Actions
SO ORDERED
2017-09-15
1
No Actions
ORAL ORDER: The Markman hearing scheduled for 9/20/2017, is CANCELED, and will be rescheduled for a date to be determined. Ordered by Judge Richard G. Andrews on 9/18/2017. (nms) (Entered: 09/18/2017)
2017-09-18
1
1 - Terminate Deadlines AND 1 - Terminate Hearings AND Oral Order
2017-09-18
1
No Actions
NOTICE OF SERVICE of Opening Expert Report of Prof. Dr. Theo Bodewig filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 09/19/2017)
2017-09-19
1
ORDER Amending the Scheduling Orders. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 9/21/17. (cak) (Entered: 09/21/2017)
2017-09-21
1
Pro Hac Vice Attorney William D. Marsillo for Sanofi Winthrop Industrie, for Sanofi-Aventis Deutschland GmbH, and for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers.
2017-09-21
1
No Actions
Add Attorneys - PHV only
2017-09-21
1
No Actions
NOTICE to Take Deposition of Jeffrey Givand on October 19, 2017 filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 09/25/2017)
2017-09-25
1
NOTICE to Take Deposition of Peter Basile on October 18, 2017 filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 09/25/2017)
2017-09-25
1
NOTICE to Take Deposition of Jason Cheung on October 16, 2017 filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 09/25/2017)
2017-09-25
1
NOTICE OF SERVICE of Defendant Merck Sharp & Dohme Corp.s Fourth Set of Requests for Production of Documents & (2) Defendant Merck Sharp & Dohme Corp.s Fourth Set of Interrogatories to Plaintiffs filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 09/25/2017)
2017-09-25
1
NOTICE to Take Deposition of Michel Chartrain on October 17, 2017 filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 09/25/2017)
2017-09-25
1
NOTICE OF SERVICE of Sanofi Supplemental Objections and Responses to Merck Sharp & Dohme's Third Set of Interrogatories filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 09/25/2017)
2017-09-25
1
NOTICE OF SERVICE of 1) Notice of Deposition of Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GMBH, and Sanofi Winthrop Industrie Pursuant to Federal Rule of Civil Procedure 30(b)(6); 2) Notices of Deposition to Werner Mueller; Steffen Raab; Christian Pommereau; Angela Moscow; Norbert Lill; Volker Keuth; Anette Brunne-Schwarz; Ulrich Bruggemann; & Andreas Bode. filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 09/25/2017)
2017-09-25
1
Add Attorneys - PHV only
2017-09-26
1
No Actions
Pro Hac Vice Attorney Bill Ward for Sanofi Winthrop Industrie,Bill Ward for Sanofi-Aventis Deutschland GmbH,Bill Ward for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2017-09-26
1
No Actions
NOTICE OF SERVICE of Defendant Merck Sharp & Dohme Corp.'s: (1) Fifth Set of Requests for Production of Documents; (2) Supplemental Objections and Responses to Plaintiff's First Set of Interrogatories (No. 3); and (3) Supplemental Objections and Responses to Plaintiff's Second Set of Interrogatories (Nos. 9, 10, 12, and 15) filed by Merck Sharp & Dohme Corp..(Newell, Ryan) (Entered: 09/28/2017)
2017-09-28
1
NOTICE OF SERVICE of Fourth Set of Requests for Admission (Nos. 41-100) and Fourth Set of Interrogatories (Nos. 21 - 25) filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 09/29/2017)
2017-09-29
1
NOTICE of Appearance by Kelly A Del Dotto on behalf of Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC (Del Dotto, Kelly) (Entered: 09/29/2017)
2017-09-29
1
NOTICE to Take Deposition of Catherine Kohler on October 27, 2017 filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 10/06/2017)
2017-10-06
1
NOTICE OF SERVICE of Testimony and Production Subpoenas re Baxter Healthcare Corporation, Baxter Pharmaceutical Solutions, LLC, and PPD Laboratories. filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 10/09/2017)
2017-10-09
1
STIPULATION and Order Amending Scheduling Order With Respect to Certain Discovery Dates - filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) Modified on 10/12/2017 (nms). (Entered: 10/12/2017)
2017-10-12
1
NOTICE OF SERVICE of Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GmBH, and Sanofi Winthrop Industries Supplemental Objections and Responses to Merck Sharp & Dohmes Third Set of Interrogatories (7, 8, and 11) filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 10/12/2017)
2017-10-12
1
Motions No Longer Referred
2017-10-12
1
No Actions
SO ORDERED
2017-10-12
1
No Actions
SO ORDERED, re 151 STIPULATION and Order Amending Scheduling Order With Respect to Certain Discovery Dates. Signed by Judge Richard G. Andrews on 10/12/2017. (nms)
2017-10-12
1
No Actions
Motions No Longer Referred: 151 STIPULATION and Order Amending Scheduling Order With Respect to Certain Discovery Dates. (nms)
2017-10-12
1
No Actions
ORAL ORDER: The Markman Hearing is now rescheduled for 11/6/2017, at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 10/17/2017. (nms) (Entered: 10/17/2017)
2017-10-17
1
Oral Order AND ~Util - Set Hearings
2017-10-17
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Excylyn Hardin-Smith - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certification)(Golden, Ronald) (Entered: 10/18/2017)
2017-10-18
1
SO ORDERED
2017-10-18
1
No Actions
SO ORDERED, re 154 MOTION for Pro Hac Vice Appearance of Attorney Excylyn Hardin-Smith, filed by Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 10/18/2017. (nms)
2017-10-18
1
No Actions
STIPULATION and Order to extend time, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 10/26/2017 (nms). (Entered: 10/26/2017)
2017-10-26
1
SO ORDERED
2017-10-26
1
No Actions
SO ORDERED, re 155 Stipulation and Order to extend time. Signed by Judge Richard G. Andrews on 10/26/2017. (nms)
2017-10-26
1
No Actions
NOTICE OF SERVICE of Responsive Expert Report of Prof. Dr. Theo Bodewig and Expert Report of Dr. Charles F. Reinholtz filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 10/27/2017)
2017-10-27
1
Letter to The Honorable Richard G. Andrews from Arthur G. Connolly III regarding Claim Construction Hearing. (Connolly, Arthur) Modified on 10/31/2017 (nms). (Entered: 10/31/2017)
2017-10-31
1
ORAL ORDER: The requests in D.I. 157 are DENIED. Ordered by Judge Richard G. Andrews on 10/31/2017. (nms) (Entered: 10/31/2017)
2017-10-31
1
Oral Order
2017-10-31
1
No Actions
NOTICE OF SERVICE of Objections and Responses to Fourth Interrogatories, Supplemental Objections and Responses to Third Interrogatories, and Second Infringement Contentions filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Del Dotto, Kelly) (Entered: 11/03/2017)
2017-11-03
1
ADDITIONAL Agreed Construction for the Amended Joint Claim Construction Brief, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 11/7/2017 (nms). (Entered: 11/06/2017)
2017-11-06
1
Markman Hearing
2017-11-06
1
No Actions
Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 11/6/2017. (Court Reporter Leonard Dibbs.) (ksr, )
2017-11-06
1
No Actions
STIPULATION Expert Reports relating to infringement and invalidity aspects of case by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 11/07/2017)
2017-11-07
1
SO ORDERED
2017-11-07
1
No Actions
SO ORDERED, re 161 Stipulation and Order amending scheduling order. Signed by Judge Richard G. Andrews on 11/7/2017. (nms)
2017-11-07
1
No Actions
NOTICE to Take Deposition of Joerg Von Eysmondt on November 10, 2017 filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 11/09/2017)
2017-11-09
1
NOTICE to Take Deposition of Paul Stevenson (30(b)(1) on November 10, 2017 filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 11/09/2017)
2017-11-09
1
Official Transcript of Markman Hearing held on 11-06-17 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 12/1/2017. Redacted Transcript Deadline set for 12/11/2017. Release of Transcript Restriction set for 2/8/2018. (lad) (Entered: 11/10/2017)
2017-11-10
1
NOTICE OF SERVICE of Objections and Responses to Plaintiffs' Fourth Set of Interrogatories to Defendant (Nos. 21-25) and Objections and Responses to Plaintiffs' Fourth Set of Requests for Admission to Defendant (Nos. 41-100) filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 11/14/2017)
2017-11-14
1
STIPULATION to extend deadline to serve Reply Expert Reports regarding license and exhaustion until 11/29/2017 by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 11/16/2017)
2017-11-16
1
SO ORDERED
2017-11-16
1
No Actions
SO ORDERED re 166 Stipulation and Proposed Amended Scheduling Order with Respect to Certain Discovery Dates. The following deadlines on licensing/exhaustion issues set forth under the Scheduling Order 17 and as amended at 70, 75, 83, and 151 shall be amended as follows: Paragraph 10(a) Reply Expert Reports regarding license and exhaustion shall now be due 11/29/17. Signed by Judge Mary Pat Thynge on 11/16/17. (cak)
2017-11-16
1
No Actions
NOTICE to Take Deposition of Paul Jansen on November 28, 2017 filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 11/22/2017)
2017-11-22
1
NOTICE to Take Deposition of Christoph Dette on December 1, 2017 filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) (Entered: 11/29/2017)
2017-11-29
1
Letter to Honorable Richard G. Andrews from Ronald P. Golden III regarding asserted claims. (Golden, Ronald) (Entered: 12/14/2017)
2017-12-14
1
Letter to Honorable Richard G. Andrews from Ronald P. Golden III regarding PTAB review of patents - re 88 Letter. (Golden, Ronald) (Entered: 12/15/2017)
2017-12-15
1
NOTICE OF SERVICE of Plaintiffs' Third Supplemental Initial Disclosures; Supplemental Objections and Responses to Merck's 4th Set of Interrogatories (No. 22); Supplemental Objections and Responses to Merck's Third Set of Interrogatories (No. 7, 10, and 14); and Third Supplemental Disclosure of Asserted Charts, with Exhibits A-J filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 12/18/2017)
2017-12-18
1
NOTICE OF SERVICE of Plaintiffs' Fourth Supplemental Initial Disclosures filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) (Entered: 12/18/2017)
2017-12-18
1
STIPULATION Amending Scheduling Order with Respect to Certain Discovery Dates by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 12/18/2017)
2017-12-18
1
SO ORDERED
2017-12-19
1
No Actions
SO ORDERED, re 173 Stipulation and Order Amending Scheduling Order with Respect to Certain Discovery Dates. Signed by Judge Richard G. Andrews on 12/19/2017. (nms)
2017-12-19
1
No Actions
MOTION to Expand Page Limits of Summary Judgment Briefing - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Proposed Order).(Connolly, Arthur) Modified on 1/2/2018 (nms). (Entered: 12/27/2017)
2017-12-27
1
Unopposed Motion and Proposed Order to Expedite Briefing - filed by Merck Sharp & Dohme Corp..(Connolly, Arthur) Modified on 12/28/2017 (nms). Modified on 12/28/2017 (nms). (Entered: 12/27/2017)
2017-12-27
1
Set Answering Brief Deadline re 174 MOTION to Expand Page Limits of Summary Judgment Briefing. Answering Brief/Response due date per Local Rules is 1/10/2018. (nms)
2017-12-27
1
No Actions
RESPONSE to 174 MOTION to Expand Page Limits of Summary Judgment Briefing, filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Golden, Ronald) Modified on 12/28/2017 (nms). (Entered: 12/28/2017)
2017-12-28
1
[SEALED] REPLY Brief re 174 MOTION to Expand Page Limits of Summary Judgment Briefing, filed by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 1/2/2018 (nms). (Entered: 12/28/2017)
2017-12-28
1
Letter to The Honorable Richard G. Andrews from Arthur G. Connolly, III, Esq. regarding Motion to Expand Page Limits of Summary Judgment Briefing - re 174 MOTION to Expand Page Limits of Summary Judgment Briefing . (Connolly, Arthur) (Entered: 12/28/2017)
2017-12-28
1
SO ORDERED AND ~Util - Set Briefing Schedule - open,ans,reply,surreply
2017-12-28
1
No Actions
-SET ANSWERING BRIEF - no open brief w/ Motion
2017-12-28
1
No Actions
Motions No Longer Referred
2017-12-28
1
No Actions
SO ORDERED, re 175 Unopposed Motion and Proposed Order to Expedite Briefing (*Reset Briefing Schedule: re 174 MOTION to Expand Page Limits of Summary Judgment Briefing. Answering Brief due 12/28/2017, Reply Brief due 12/28/2017). Signed by Judge Richard G. Andrews on 12/28/2017. (nms)
2017-12-28
1
No Actions
Motions No Longer Referred: 175 Unopposed Motion and Proposed Order to Expedite Briefing. (nms)
2017-12-28
1
No Actions
NOTICE of Withdrawal of Motion to Expand Page Limits of Summary Judgment Briefing (D.I. 174 ), by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 1/2/2018 (nms). (Entered: 01/02/2018)
2018-01-02
1
MOTION for Summary Judgment of Noninfringement of U.S. Patent Nos. 8,603,044; 8,992,486; 8,679,069; 9,526,844; 9,533,105; & 9,604,008 - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Proposed Order)(Connolly, Arthur) Modified on 1/3/2018 (nms). (Entered: 01/02/2018)
2018-01-02
1
[SEALED] OPENING BRIEF in Support re 180 MOTION for Summary Judgment of Noninfringement of U.S. Patent Nos. 8,603,044; 8,992,486; 8,679,069; 9,526,844; 9,533,105; & 9,604,008, filed by Merck Sharp & Dohme Corp..Answering Brief/Response due date per Local Rules is 1/16/2018. (Connolly, Arthur) Modified on 1/3/2018 (nms). (Main Document 181 replaced on 1/11/2018) (nms). (Entered: 01/02/2018)
2018-01-02
1
[SEALED] APPENDIX to 181 Opening Brief in Support, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 1/3/2018 (nms). (Entered: 01/02/2018)
2018-01-02
1
REDACTED VERSION of 177 Reply in Support, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 1/8/2018 (nms). (Entered: 01/05/2018)
2018-01-05
1
MOTION to Extend Technical Expert Report Deadlines - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Golden, Ronald) Modified on 1/8/2018 (nms). (Entered: 01/08/2018)
2018-01-08
1
MOTION to Extend Technical Expert Report Deadlines - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Golden, Ronald) Modified on 1/8/2018 (nms). (Entered: 01/08/2018)
2018-01-08
2
Unopposed Motion to Expedite Briefing to Extend Deadlines - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 1/9/2018 (nms). (Entered: 01/08/2018)
2018-01-08
1
MOTION for Pro Hac Vice Appearance of Attorney Ron F. Vogel - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 01/09/2018)
2018-01-09
1
REDACTED VERSION of 181 Opening Brief in Support, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Main Document 187 replaced on 1/11/2018) (nms). (Entered: 01/09/2018)
2018-01-09
1
REDACTED VERSION of 182 Appendix by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Entered: 01/09/2018)
2018-01-09
1
SO ORDERED AND ~Util - Set Briefing Schedule - open,ans,reply,surreply
2018-01-09
1
No Actions
SO ORDERED
2018-01-09
1
No Actions
SO ORDERED, re 186 MOTION for Pro Hac Vice Appearance of Attorney Ron F. Vogel, filed by Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 1/9/2018. (nms)
2018-01-09
1
No Actions
SO ORDERED, re 185 Unopposed Motion to Expedite Briefing to Extend Deadlines (*Reset Briefing Schedule: re 184 MOTION to Extend Technical Expert Report Deadlines: Answering Brief due 1/10/2018, Reply Brief due 1/11/2018). Signed by Judge Richard G. Andrews on 1/9/2018. (nms)
2018-01-09
1
No Actions
ANSWERING BRIEF in Opposition re 184 MOTION to Extend Technical Expert Report Deadlines filed by Merck Sharp & Dohme Corp..Reply Brief due date per Local Rules is 1/17/2018. (Connolly, Arthur) (Entered: 01/10/2018)
2018-01-10
1
REPLY BRIEF re 184 MOTION to Extend Technical Expert Report Deadlines filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 01/11/2018)
2018-01-11
1
ORAL ORDER: The Motion to Extend Technical Expert Report Deadlines (D.I. 184 ) is DENIED. Ordered by Judge Richard G. Andrews on 1/11/2018. (nms) (Entered: 01/11/2018)
2018-01-11
1
Oral Order
2018-01-11
1
No Actions
- CORRECTING ENTRY
2018-01-11
1
No Actions
CORRECTING ENTRY: The pdf for D.I. 181 and 187 have been replaced per counsel's request. Amendments have been made to the footnotes. Counsel will reserve the documents accordingly. (nms) Modified on 1/17/2018 (nms).
2018-01-11
1
No Actions
MEMORANDUM OPINION providing claim construction for multiple terms in U.S. Patent Nos. 8,603,044, 8,679,069, 8,992,486, 9,526,844, 9,533,105, 9,457,152, 9,592,348, 7,476,652, 7,713,930, and 9,604,008. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion. Signed by Judge Richard G. Andrews on 1/12/2018. (nms)
2018-01-12
1
STIPULATION extend expert report deadlines related to infringement and invalidity by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 01/16/2018)
2018-01-16
1
SO ORDERED
2018-01-16
1
No Actions
SO ORDERED, re 193 Stipulation and Order extending deadlines. Signed by Judge Richard G. Andrews on 1/16/2018. (nms)
2018-01-16
1
No Actions
STIPULATION and Order to extend expert reports deadlines - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 1/18/2018 (nms). (Entered: 01/18/2018)
2018-01-18
1
SO ORDERED
2018-01-18
1
No Actions
SO ORDERED, re 194 STIPULATION and Order to extend expert reports deadlines. Signed by Judge Richard G. Andrews on 1/18/2018. (nms)
2018-01-18
1
No Actions
STIPULATION extend time for parties to file proposed claim construction order, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 1/22/2018 (nms). (Entered: 01/19/2018)
2018-01-19
1
Unopposed Motion to Extend Briefing Schedule, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 1/22/2018 (nms). (Entered: 01/22/2018)
2018-01-22
1
SO ORDERED AND ~Util - Set Briefing Schedule - open,ans,reply,surreply
2018-01-22
1
No Actions
SO ORDERED
2018-01-22
1
No Actions
SO ORDERED, re 195 Stipulation and Order to extend time to submit proposed order to 1/26/2018. Signed by Judge Richard G. Andrews on 1/22/2018. (nms)
2018-01-22
1
No Actions
SO ORDERED, re 196 Unopposed Motion to Extend Briefing Schedule (*Reset Briefing Schedule: re 180 MOTION for Summary Judgment of Noninfringement of U.S. Patent Nos. 8,603,044; 8,992,486; 8,679,069; 9,526,844; 9,533,105; & 9,604,008. Answering Brief due 1/24/2018, Reply Brief due 2/5/2018). Signed by Judge Richard G. Andrews on 1/22/2018. (nms)
2018-01-22
1
No Actions
SEALED ANSWERING BRIEF in Opposition re 180 MOTION for Summary Judgment of Noninfringement of U.S. Patent Nos. 8,603,044; 8,992,486; 8,679,069; 9,526,844; 9,533,105; & 9,604,008, filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.Reply Brief due date per Local Rules is 1/31/2018. (Hufnal, AnnaMartina) Modified on 1/25/2018 (nms). (Entered: 01/24/2018)
2018-01-24
1
[SEALED] DECLARATION of Paul Jansen re 197 Answering Brief in Opposition, by Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G)(Golden, Ronald) Modified on 1/25/2018 (nms). (Entered: 01/24/2018)
2018-01-24
1
[SEALED] DECLARATION of Charles F. Reinholtz re 197 Answering Brief in Opposition, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Golden, Ronald) Modified on 1/25/2018 (nms). (Entered: 01/24/2018)
2018-01-24
1
[SEALED] DECLARATION of Prof. Dr. Theo Bodewig re 197 Answering Brief in Opposition, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A)(Golden, Ronald) Modified on 1/25/2018 (nms). (Entered: 01/24/2018)
2018-01-24
1
[SEALED] DECLARATION of Ronald P. Golden III, Volume 1 of 3, by Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47)(Golden, Ronald) Modified on 1/25/2018 (nms). (Entered: 01/24/2018)
2018-01-24
1
[SEALED] DECLARATION of Ronald P. Golden III, Volume 2 of 3 re 197 Answering Brief in Opposition, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 48, # 2 Exhibit 49, # 3 Exhibit 50, # 4 Exhibit 51, # 5 Exhibit 52, # 6 Exhibit 53, # 7 Exhibit 54, # 8 Exhibit 55, # 9 Exhibit 56, # 10 Exhibit 57, # 11 Exhibit 58, # 12 Exhibit 59, # 13 Exhibit 60, # 14 Exhibit 61, # 15 Exhibit 62, # 16 Exhibit 63, # 17 Exhibit 64, # 18 Exhibit 65, # 19 Exhibit 66, # 20 Exhibit 67, # 21 Exhibit 68, # 22 Exhibit 69, # 23 Exhibit 70, # 24 Exhibit 71, # 25 Exhibit 72, # 26 Exhibit 73, # 27 Exhibit 74, # 28 Exhibit 75, # 29 Exhibit 76, # 30 Exhibit 77, # 31 Exhibit 78, # 32 Exhibit 79, # 33 Exhibit 80, # 34 Exhibit 81, # 35 Exhibit 82, # 36 Exhibit 83, # 37 Exhibit 84, # 38 Exhibit 85)(Golden, Ronald) Modified on 1/25/2018 (nms). (Entered: 01/24/2018)
2018-01-24
1
[SEALED] DECLARATION of Ronald P. Golden III, Volume 3 of 3 re 197 Answering Brief in Opposition, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 86, # 2 Exhibit 87, # 3 Exhibit 88, # 4 Exhibit 89, # 5 Exhibit 90, # 6 Exhibit 91, # 7 Exhibit 92, # 8 Exhibit 93, # 9 Exhibit 94, # 10 Exhibit 95, # 11 Exhibit 96, # 12 Exhibit 97, # 13 Exhibit 98, # 14 Exhibit 99, # 15 Exhibit 100, # 16 Exhibit 101, # 17 Exhibit 102, # 18 Exhibit 103)(Golden, Ronald) Modified on 1/25/2018 (nms). (Entered: 01/24/2018)
2018-01-24
1
- CORRECTING ENTRY
2018-01-25
1
No Actions
CORRECTING ENTRY: D.I. 197 has been placed under seal per counsel's request. (nms)
2018-01-25
1
No Actions
PROPOSED Claim Construction Order, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 1/29/2018 (nms). (Entered: 01/26/2018)
2018-01-26
1
CLAIM CONSTRUCTION ORDER. Signed by Judge Richard G. Andrews on 1/29/2018. (nms) (Entered: 01/29/2018)
2018-01-29
1
REDACTED VERSION of 197 Answering Brief in Opposition, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) (Entered: 01/31/2018)
2018-01-31
1
REDACTED VERSION of 200 Declaration of Dr. Theo Bodewig, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A)(Golden, Ronald) Modified on 2/1/2018 (nms). (Entered: 01/31/2018)
2018-01-31
1
REDACTED VERSION of 198 Declaration of Dr. Paul Jansen, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A-G)(Golden, Ronald) Modified on 2/1/2018 (nms). (Entered: 01/31/2018)
2018-01-31
1
REDACTED VERSION of 199 Declaration of Dr. Charles Reinholtz, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibits 1-6)(Golden, Ronald) Modified on 2/1/2018 (nms). (Entered: 01/31/2018)
2018-01-31
1
REDACTED VERSION of 201 Declaration of Ronald P. Golden III, Volume 1 of 3, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibits 1-47)(Golden, Ronald) Modified on 2/1/2018 (nms). (Entered: 01/31/2018)
2018-01-31
1
REDACTED VERSION of 202 Declaration of Ronald P. Golden III, Volume 2 of 3, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibits 48-85)(Golden, Ronald) Modified on 2/1/2018 (nms). (Entered: 01/31/2018)
2018-01-31
1
REDACTED VERSION of 203 Declaration of Ronald P. Golden III, Volume 3 of 3, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibits 86-103)(Golden, Ronald) Modified on 2/1/2018 (nms). (Entered: 01/31/2018)
2018-01-31
1
[SEALED] REPLY Brief re 180 MOTION for Summary Judgment of Noninfringement of U.S. Patent Nos. 8,603,044; 8,992,486; 8,679,069; 9,526,844; 9,533,105; & 9,604,008, filed by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 2/6/2018 (nms). (Entered: 02/05/2018)
2018-02-05
1
[SEALED] Supplemental Appendix to 213 Reply Brief, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 2/6/2018 (nms). (Entered: 02/05/2018)
2018-02-05
1
NOTICE to Take Deposition of Howard Jordi on February 8, 2018 filed by Merck Sharp & Dohme Corp..(Akhimien, Mary) (Entered: 02/07/2018)
2018-02-07
1
JOINT REQUEST for Oral Argument, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC re 180 MOTION for Summary Judgment of Noninfringement of U.S. Patent Nos. 8,603,044; 8,992,486; 8,679,069; 9,526,844; 9,533,105; & 9,604,008. (Hufnal, AnnaMartina) Modified on 2/12/2018 (nms). (Entered: 02/09/2018)
2018-02-09
1
Letter to Chief Magistrate Judge Mary Pat Thynge from Arthur G. Connolly, III, Esq. regarding Jordi Labs Deposition. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3)(Connolly, Arthur) (Additional attachment(s) added on 2/12/2018: # 3 Proposed Order) (nms). (Entered: 02/12/2018)
2018-02-12
1
[SEALED] EXHIBIT 1 to 217 Letter, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 2/12/2018 (nms). (Entered: 02/12/2018)
2018-02-12
1
[SEALED] MOTION to Strike or, in the Alternative, for Leave to File a Sur-Reply - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Hufnal, AnnaMartina) Modified on 2/13/2018 (nms). (Entered: 02/12/2018)
2018-02-12
1
[SEALED] DECLARATION of Ronald P. Golden III re 219 MOTION to Strike or, in the Alternative, for Leave to File a Sur-Reply, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F)(Golden, Ronald) Modified on 2/13/2018 (nms). (Entered: 02/12/2018)
2018-02-12
1
REDACTED VERSION of 213 Reply Brief, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 2/13/2018 (nms). (Entered: 02/12/2018)
2018-02-12
1
REDACTED VERSION of 214 Appendix by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Entered: 02/12/2018)
2018-02-12
1
- CORRECTING ENTRY
2018-02-12
1
No Actions
CORRECTING ENTRY: D.I. 219 has been removed from the docket. The proposed order filed at that entry has been added to D.I. 217 . (nms)
2018-02-12
1
No Actions
Set Answering Brief Deadline re 219 MOTION to Strike or, in the Alternative, for Leave to File a Sur-Reply. Answering Brief/Response due date per Local Rules is 2/26/2018. (nms)
2018-02-12
1
No Actions
CERTIFICATE Of Service re 218 Sealed Exhibit, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 2/13/2018 (nms). (Main Document 223 replaced on 2/13/2018) (nms). (Entered: 02/13/2018)
2018-02-13
1
[SEALED] Letter to Honorable Chief Magistrate Judge Mary Pat Thynge from Martina Tyreus Hufnal regarding deposition of Dr. Xu - re 217 Letter,. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Hufnal, AnnaMartina) (Entered: 02/13/2018)
2018-02-13
1
NOTICE OF SERVICE re 219 Sealed MOTION to Strike or, in the Alternative, for Leave to File a Sur-Reply, and 220 Sealed Declaration, filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC.(Golden, Ronald) Modified on 2/13/2018 (nms). (Entered: 02/13/2018)
2018-02-13
1
- CORRECTING ENTRY
2018-02-13
1
No Actions
-SET ANSWERING BRIEF - no open brief w/ Motion
2018-02-13
1
No Actions
CORRECTING ENTRY: The pdf for D.I. 223 has been replaced with a corrected version. The date reflected on the document has been amended. (nms)
2018-02-13
1
No Actions
REDACTED VERSION of 218 Exhibit to a Document by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Entered: 02/14/2018)
2018-02-14
1
[SEALED] Letter to Honorable Chief Magistrate Judge Mary Pat Thynge, from Martina Tyreus Hufnal, regarding Dr. Xu deposition (see D.I. 224 ). (Attachments: # 1 Jordi Declaration)(Hufnal, AnnaMartina) Modified on 2/15/2018 (nms). (Entered: 02/14/2018)
2018-02-14
1
Telephone Conference
2018-02-15
1
No Actions
Minute Entry for proceedings held before Judge Mary Pat Thynge - Telephone Conference re: discovery dispute held on 2/15/2018 The transcript shall serve as the order of the Court; ATTENDES: PLTFF. - A. Hufnal, Esq.; M. Underhill, Esq.; DEFT. - A. Connolly, Esq.; CLERK - Kincaid. (Court Reporter Taneyah Carroll.) (kjk)
2018-02-15
1
No Actions
STIPULATION to Extend Time to Serve Rebuttal Expert Reports, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 2/20/2018 (nms). (Entered: 02/19/2018)
2018-02-19
1
SO ORDERED
2018-02-20
1
No Actions
SO ORDERED, re 228 Stipulation to Extend Time to Serve Rebuttal Expert Reports. Signed by Judge Richard G. Andrews on 2/20/2018. (nms)
2018-02-20
1
No Actions
REDACTED VERSION of 219 MOTION to Strike or for Leave to file a Sur-Reply, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Golden, Ronald) Modified on 2/22/2018 (nms). (Entered: 02/22/2018)
2018-02-22
1
REDACTED VERSION of 220 Declaration of Ronald P. Golden, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F)(Golden, Ronald) Modified on 2/22/2018 (nms). (Entered: 02/22/2018)
2018-02-22
1
REDACTED VERSION of 227 Letter, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration)(Golden, Ronald) Modified on 2/26/2018 (nms). (Entered: 02/23/2018)
2018-02-23
1
Deficiency re Redacted Documents
2018-02-23
1
No Actions
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 224 . (nms)
2018-02-23
1
No Actions
[SEALED] ANSWERING BRIEF in Opposition re 219 MOTION to Strike filed by Merck Sharp & Dohme Corp..Reply Brief due date per Local Rules is 3/5/2018. (Connolly, Arthur) (Entered: 02/26/2018)
2018-02-26
1
[SEALED] DECLARATION of Gregory D. Bonifield, Esq. re 232 Answering Brief in Opposition, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Connolly, Arthur) Modified on 2/27/2018 (nms). (Entered: 02/26/2018)
2018-02-26
1
REDACTED VERSION of 224 Letter, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibits A-H)(Golden, Ronald) Modified on 2/27/2018 (nms). (Entered: 02/27/2018)
2018-02-27
1
SECOND REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 224 . (nms)
2018-02-27
1
No Actions
Deficiency re Redacted Documents
2018-02-27
1
No Actions
[SEALED] REPLY BRIEF re 219 MOTION to Strike filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) (Entered: 03/05/2018)
2018-03-05
1
REDACTED VERSION of 232 Answering Brief in Opposition by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Entered: 03/05/2018)
2018-03-05
1
REDACTED VERSION of 233 Declaration by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Entered: 03/05/2018)
2018-03-05
1
REDACTED VERSION of 235 Reply Brief, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 3/13/2018 (nms). (Entered: 03/12/2018)
2018-03-12
1
ORDER Setting Teleconference: Defense counsel to initiate the call. A Telephone Conference is set for 4/27/2018 at 10:00 AM Eastern Time before Judge Mary Pat Thynge to address a discovery issue. Signed by Judge Mary Pat Thynge on 4/3/18. (cak) (Entered: 04/03/2018)
2018-04-03
1
MOTION for Pro Hac Vice Appearance of Attorney Elizabeth Stotland Weiswasser and Aaron L. J. Pereira - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 04/20/2018)
2018-04-20
1
Letter to Chief Magistrate Judge Mary Pat Thynge from Arthur G. Connolly, III, regarding request for Court to strike all testing (see D.I. 217 ). (Attachments: # 1 Exhibit 2)(Connolly, Arthur) Modified on 4/23/2018 (cak). Modified on 4/23/2018 (nms). (Main Document 241 replaced on 4/23/2018) (nms). (Entered: 04/23/2018)
2018-04-23
1
[SEALED] EXHIBITS 1 and 3 to 241 Letter, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Certificate of Service)(Connolly, Arthur) Modified on 4/23/2018 (nms). (Entered: 04/23/2018)
2018-04-23
1
SO ORDERED, re 240 MOTION for Pro Hac Vice Appearance of Attorney Elizabeth Stotland Weiswasser and Aaron L. J. Pereira, filed by Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 4/23/2018. (nms)
2018-04-23
1
No Actions
CORRECTING ENTRY: The docket language for DI 241 was corrected to read "Letter to The Honorable Mary Pat Thynge" instead of "The Honorable Leonard P. Start." (cak)
2018-04-23
1
No Actions
CORRECTING ENTRY: The main pdf for D.I. 241 has been replaced per counsel's request. Typographical errors have been corrected. (nms)
2018-04-23
1
No Actions
[SEALED] Letter to Chief Magistrate Judge Thynge, from Martina Tyreus Hufnal, regarding response to Letter (D.I. 241 ). (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Hufnal, AnnaMartina) Modified on 4/24/2018 (nms). (Entered: 04/24/2018)
2018-04-24
1
ORAL ORDER re 241, 242, and 243 . The transcript of the teleconference held on 4/27/18 with Judge Thynge shall serve as the Order of the Court. Ordered by Judge Mary Pat Thynge on 4/27/18. (cak) (Entered: 04/27/2018)
2018-04-27
1
Minute Entry for proceedings held before Judge Mary Pat Thynge - Telephone Conference re: discovery dispute held on 4/27/2018; The transcript shall serve as the order of the court. ATTENDEES: PLTFF - M. Underhill, Esq.; J. Goetz, Esq.; M. Hufnal, Esq.; S. Donahue, Esq.; W. Ward, Esq., DEFT - M. Traupman, Esq.; A. Antons, Esq.; A. Connolly, III, Esq.; G. Bonifield, Esq.; CLERK - Kincaid (Court Reporter Taneyah Carroll.) (kjk)
2018-04-27
1
No Actions
Official Transcript of Teleconference held on 08-01-17 before Judge Mary Pat Thynge. Court Reporter/Transcriber Taneha Carroll. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 5/21/2018. Redacted Transcript Deadline set for 5/31/2018. Release of Transcript Restriction set for 7/30/2018. (lad) (Entered: 04/30/2018)
2018-04-30
1
Official Transcript of Teleconference held on 02-15-18 before Judge Mary Pat Thynge. Court Reporter/Transcriber Taneha Carroll. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 5/21/2018. Redacted Transcript Deadline set for 5/31/2018. Release of Transcript Restriction set for 7/30/2018. (lad) (Entered: 04/30/2018)
2018-04-30
1
Official Transcript of Teleconference held on 04-27-18 before Judge Mary Pat Thynge. Court Reporter/Transcriber Taneha Carroll. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 5/21/2018. Redacted Transcript Deadline set for 5/31/2018. Release of Transcript Restriction set for 7/30/2018. (lad) (Entered: 04/30/2018)
2018-04-30
1
Official Transcript of Teleconference held on 08-31-17 before Judge Mary Pat Thynge. Court Reporter/Transcriber Taneha Carroll. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 5/21/2018. Redacted Transcript Deadline set for 5/31/2018. Release of Transcript Restriction set for 7/30/2018. (lad) (Entered: 04/30/2018)
2018-04-30
1
REDACTED VERSION of 242 Exhibit to a Document by Merck Sharp & Dohme Corp.. (Connolly, Arthur) (Entered: 05/01/2018)
2018-05-01
1
REDACTED VERSION of 243 Letter, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Hufnal, AnnaMartina) Modified on 5/2/2018 (nms). (Entered: 05/01/2018)
2018-05-01
1
Letter to The Honorable Richard G. Andrews from Arthur G. Connolly, III, Esq. regarding Trial Schedule. (Connolly, Arthur) (Entered: 05/02/2018)
2018-05-02
1
[SEALED] MOTION to Exclude Testimony of Dr. John McLean - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate of Service).(Hufnal, AnnaMartina) Modified on 5/4/2018 (nms). (Entered: 05/03/2018)
2018-05-03
1
[SEALED] MOTION to Exclude Testimony of Dr. Rodolfo Pinal - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate of Service).(Hufnal, AnnaMartina) Modified on 5/4/2018 (nms). (Entered: 05/03/2018)
2018-05-03
1
[SEALED] DECLARATION of Martina Tyreus Hufnal re 253 MOTION to Exclude Testimony of Dr. Rodolfo Pinal, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Hufnal, AnnaMartina) Modified on 5/4/2018 (nms). (Entered: 05/03/2018)
2018-05-03
1
[SEALED] DECLARATION of Martina Tyreus Hufnal re 252 MOTION to Exclude Testimony, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Hufnal, AnnaMartina) Modified on 5/4/2018 (nms). (Entered: 05/03/2018)
2018-05-03
1
Set Answering Brief Deadline re 252 MOTION to Exclude Testimony of Dr. John McLean, 253 MOTION to Exclude Testimony of Dr. Rodolfo Pinal. Answering Brief/Response due date per Local Rules is 5/17/2018. (nms)
2018-05-03
1
No Actions
Letter to Honorable Richard G. Andrews, from Martina Tyreus Hufnal, regarding response to Merck's letter regarding trial (D.I. 251 ). (Attachments: # 1 Exhibit A)(Hufnal, AnnaMartina) Modified on 5/7/2018 (nms). (Entered: 05/04/2018)
2018-05-04
1
Motions No Longer Referred: 252 MOTION to Preclude Testimony of Dr. John McLean, and 253 MOTION to Preclude Testimony of Dr. Rodolfo Pinal. (nms)
2018-05-04
1
No Actions
ORAL ORDER: The Court denies Mercks request (D.I. 251 ) for more time. The Court notes that Plaintiff has, since Mercks letter, cut the number of asserted claims in half. (D.I. 256 ). I understand that does not result in a proportional reduction of trial length. Merck may need to trim its defenses, as requested by Sanofi, but that is something we can discuss if Merck does not voluntarily take such action. I expect each side will get 14 hours. I think that is enough. Expert resumes can be submitted in advance. Ordered by Judge Richard G. Andrews on 5/7/2018. (nms) (Entered: 05/07/2018)
2018-05-07
1
REDACTED VERSION of 252 MOTION to Exclude Testimony of Dr. John McLean, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 5/14/2018 (nms). (Entered: 05/10/2018)
2018-05-10
1
REDACTED VERSION of 253 MOTION to Exclude Testimony of Dr. Rodolfo Pinal, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 5/14/2018 (nms). (Entered: 05/10/2018)
2018-05-10
1
REDACTED VERSION of 254 Declaration of Martina Tyreus Hufnal, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibits 1-5)(Golden, Ronald) Modified on 5/14/2018 (nms). (Entered: 05/10/2018)
2018-05-10
1
REDACTED VERSION of 255 Declaration Martina Tyreus Hufnal, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibits 1-6, # 2 Exhibits 7-8, # 3 Exhibits 9-11, # 4 Exhibits 12-14, # 5 Exhibits 15-16, # 6 Exhibits 17-18)(Golden, Ronald) Modified on 5/14/2018 (nms). (Entered: 05/10/2018)
2018-05-10
1
CORRECTING ENTRY: The links in D.I. 258 and D.I. 259 have been corrected so that these redactions now correctly reflect the sealed filings they are related with. (nms)
2018-05-14
1
No Actions
[SEALED] Proposed Pretrial Order, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Hufnal, AnnaMartina) Modified on 5/16/2018 (nms). Modified on 5/16/2018 (nms). (Attachment 1 replaced on 5/17/2018) (ksr, ). (Entered: 05/15/2018)
2018-05-15
1
[SEALED] Proposed Pretrial Order, Volume II of II, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 15, # 2 Exhibit 16.1, # 3 Exhibit 16.1A, # 4 Exhibit 16.1B, # 5 Exhibit 16.2, # 6 Exhibit 16.2A, # 7 Exhibit 16.2B)(Hufnal, AnnaMartina) Modified on 5/16/2018 (nms). (Entered: 05/16/2018)
2018-05-16
1
CORRECTING ENTRY: Exhibits 15 through 16.2B have been removed from D.I. 262 . Counsel will refile these exhibits in a volume II to the Pretrial Order. (nms)
2018-05-16
1
No Actions
MEMORANDUM ORDER: Defendant's motion for summary judgment (D.I. 180 ) is DENIED. Plaintiff's motion to strike (D.I. 219 ) is DISMISSED as MOOT. Signed by Judge Richard G. Andrews on 5/16/2018. (nms)
2018-05-17
1
ORDER ON MOTIONS IN LIMINE. Signed by Judge Richard G. Andrews on 5/17/2018. (nms) (Entered: 05/17/2018)
2018-05-17
1
ANSWERING BRIEF in Opposition re 252 MOTION to Exclude Testimony of Dr. John McLean filed by Merck Sharp & Dohme Corp..Reply Brief due date per Local Rules is 5/24/2018. (Connolly, Arthur) (Entered: 05/17/2018)
2018-05-17
1
DECLARATION of Matthew A. Traupman, Esq. re 266 Answering Brief in Opposition, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 5, # 4 Exhibit 6, # 5 Exhibit 7, # 6 Exhibit 8, # 7 Exhibit 9, # 8 Exhibit 10, # 9 Exhibit 11, # 10 Exhibit 12, # 11 Exhibit 14, # 12 Exhibit 15, # 13 Exhibit 16)(Connolly, Arthur) Modified on 5/21/2018 (nms). (Entered: 05/17/2018)
2018-05-17
1
[SEALED] EXHIBITS to 267 Declaration, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 13, # 4 Certificate of Service)(Connolly, Arthur) Modified on 5/21/2018 (nms). (Entered: 05/17/2018)
2018-05-17
1
ANSWERING BRIEF in Opposition re 253 MOTION to Exclude Testimony of Dr. Rodolfo Pinal filed by Merck Sharp & Dohme Corp..Reply Brief due date per Local Rules is 5/24/2018. (Connolly, Arthur) (Entered: 05/17/2018)
2018-05-17
1
DECLARATION of Matthew A. Traupman, Esq. re 269 Answering Brief in Opposition, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibit 4)(Connolly, Arthur) Modified on 5/21/2018 (nms). (Entered: 05/17/2018)
2018-05-17
1
[SEALED] EXHIBITS to 270 Declaration, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Certificate of Service)(Connolly, Arthur) Modified on 5/21/2018 (nms). (Entered: 05/17/2018)
2018-05-17
1
CORRECTING ENTRY: The PDF of Exhibit 1 of D.I. 262 has been replaced with the corrected version of the document. (ksr, )
2018-05-17
1
No Actions
Minute Entry for proceedings held before Judge Richard G. Andrews - Final Pretrial Conference held on 5/18/2018. (Court Reporter Valerie Gunning.) (ksr, )
2018-05-18
1
No Actions
Official Transcript of pretrial conference held on May 18, 2018 before Judge Andrews. Court Reporter/Transcriber Valerie Gunning,Telephone number (302) 573-6194. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/11/2018. Redacted Transcript Deadline set for 6/21/2018. Release of Transcript Restriction set for 8/20/2018. (vjg) (Entered: 05/21/2018)
2018-05-21
1
ORDER After Pretrial Conference (see Order for further details). Signed by Judge Richard G. Andrews on 5/18/2018. (nms) (Entered: 05/21/2018)
2018-05-21
1
[SEALED] REPLY BRIEF re 253 MOTION to Exclude Testimony of Dr. Rodolfo Pinal filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) (Entered: 05/22/2018)
2018-05-22
1
[SEALED] DECLARATION of Martina Tyreus Hufnal re 274 Reply Brief, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Hufnal, AnnaMartina) Modified on 5/23/2018 (nms). (Entered: 05/22/2018)
2018-05-22
1
[SEALED] REPLY BRIEF re 252 MOTION to Exclude Testimony of Dr. John McLean filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) (Entered: 05/22/2018)
2018-05-22
1
[SEALED] DECLARATION of Martina Tyreus Hufnal re 276 Reply Brief, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Hufnal, AnnaMartina) Modified on 5/23/2018 (nms). (Entered: 05/22/2018)
2018-05-22
1
REDACTED VERSION of 262 Proposed Pretrial Order,, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-12, # 3 Exhibit 13-14)(Hufnal, AnnaMartina) (Entered: 05/22/2018)
2018-05-22
1
REDACTED VERSION of 263 Proposed Pretrial Order, Volume II, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 15, # 2 Exhibit 16)(Hufnal, AnnaMartina) Modified on 5/23/2018 (nms). (Entered: 05/22/2018)
2018-05-22
1
Letter to Honorable Richard G. Andrews from Martina Tyreus Hufnal, enclosing curriculum vitae of its experts. (Attachments: # 1 Armstrong, # 2 Bodewig, # 3 Goland, # 4 Grabowski, # 5 Kirsch, # 6 Reinholtz, # 7 Veasey)(Hufnal, AnnaMartina) Modified on 5/23/2018 (nms). (Entered: 05/23/2018)
2018-05-23
1
[SEALED] Letter to Honorable Richard G. Andrews from Martina Tyreus Hufnal regarding outstanding issues for trial. (Attachments: # 1 Exhibit 1)(Hufnal, AnnaMartina) (Entered: 05/23/2018)
2018-05-23
1
Letter to The Honorable Richard G. Andrews, from Arthur G. Connolly, III, enclosing expert curriculum vitae. (Attachments: # 1 Exhibit 1, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Connolly, Arthur) Modified on 5/23/2018 (nms). (Entered: 05/23/2018)
2018-05-23
1
REDACTED VERSION of 268 Sealed Exhibits, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 5/29/2018 (nms). (Entered: 05/24/2018)
2018-05-24
1
REDACTED VERSION of 271 Sealed Exhibits, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 5/29/2018 (nms). (Entered: 05/24/2018)
2018-05-24
1
STIPULATION of Judgment of Non-Infringement and Dismissal of Counterclaims, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) Modified on 5/29/2018 (nms). (Entered: 05/28/2018)
2018-05-28
1
ORDER For Judgment of Non-Infringement and Dismissal of Counterclaims. Signed by Judge Richard G. Andrews on 5/29/2018. (nms) (Entered: 05/29/2018)
2018-05-29
1
MEMORANDUM ORDER: The Motion to Exclude the Testimony of Dr. John McLean (D.I. 253 ) is DENIED without prejudice, and the Motion to Exclude the Testimony of Dr. Rodolfo Pinal (D.I. 253 ) is DENIED without prejudice. Signed by Judge Richard G. Andrews on 5/29/2018. (nms)
2018-05-29
1
ORDER NARROWING ISSUES FOR TRIAL. Signed by Judge Richard G. Andrews on 5/29/2018. (nms) (Entered: 05/29/2018)
2018-05-29
1
Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial, day 1 held on 5/29/2018. (Court Reporter Valerie Gunning/Leonard Dibbs.) (ksr, )
2018-05-29
1
No Actions
Letter to Honorable Richard G. Andrews from Martina Tyreus Hufnal regarding Doctrine of Equivalents. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Hufnal, AnnaMartina) (Entered: 05/30/2018)
2018-05-30
1
[SEALED] Letter to Honorable Richard G. Andrews from Martina Tyreus Hufnal regarding Prevent Testimony and Argument Comparing the Accused Device to Sanofi's Validity Theories. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Hufnal, AnnaMartina) (Entered: 05/30/2018)
2018-05-30
1
Letter to Judge Richard G. Andrews from Arthur G. Connolly, III regarding Response to Sanofi's Doctrine of Equivalents Letter - re 289 Letter. (Connolly, Arthur) (Entered: 05/30/2018)
2018-05-30
1
Letter to Judge Richard G. Andrews from Arthur G. Connolly, III regarding Response to Sanofi's Letter regarding Tubular Clutch - re 290 Letter,. (Connolly, Arthur) (Entered: 05/30/2018)
2018-05-30
1
Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial, day 2 held on 5/30/2018. (Court Reporter Valerie Gunning/Leonard Dibbs.) (ksr, )
2018-05-30
1
No Actions
MOTION for Judgment on Defendants' Defense that the '652 Patent is Invalid - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) Modified on 5/31/2018 (nms). (Entered: 05/31/2018)
2018-05-31
1
MOTION for Judgment on Defendants' License and Exhaustion Defenses - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Hufnal, AnnaMartina) Modified on 5/31/2018 (nms). (Entered: 05/31/2018)
2018-05-31
1
MOTION for Pro Hac Vice Appearance of Attorney William Bloom - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) (Entered: 05/31/2018)
2018-05-31
1
Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial, day 3 held on 5/31/2018. (Court Reporter Valerie Gunning/Leonard Dibbs.) (ksr, )
2018-05-31
1
No Actions
SO ORDERED, re 295 MOTION for Pro Hac Vice Appearance of Attorney William Bloom, filed by Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 6/1/2018. (nms)
2018-06-01
1
No Actions
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of redacted versions of DI # 274, 275, 276, and 277 . (nms)
2018-06-01
1
No Actions
Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial, day 4 held on 6/1/2018. (Court Reporter Valerie Gunning/Leonard Dibbs.) (ksr, )
2018-06-01
1
No Actions
Proposed Order, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) Modified on 6/4/2018 (nms). (Entered: 06/04/2018)
2018-06-04
1
SO ORDERED, re 296 Joint Proposed Order regarding post-trial briefing. Signed by Judge Richard G. Andrews on 6/4/2018. (nms) (Entered: 06/04/2018)
2018-06-04
1
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 281 . (nms)
2018-06-04
1
No Actions
Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial, day 5 completed on 6/4/2018. (Court Reporter Valerie Gunning.) (ksr, )
2018-06-04
1
No Actions
ORAL ORDER: IT IS ORDERED, D.I. 294 MOTION for Judgment on Defendants' License and Exhaustion Defenses, and D.I. 293 MOTION for Judgment on Defendants' Defense that the '652 Patent is Invalid are both DENIED. Ordered by Judge Richard G. Andrews on 6/5/2018. (ksr, ) (Entered: 06/05/2018)
2018-06-05
1
Witness List from Bench Trial held 5/29/2018 - 6/4/2018. (ksr, ) (Entered: 06/06/2018)
2018-06-06
1
Exhibit List from Bench Trial held 5/29/2018 - 6/4/2018. (ksr, ) Modified on 12/14/2018 (ksr, ). (Entered: 06/06/2018)
2018-06-06
1
SECOND REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of redacted versions of DI # 274, 275, 276, and 277 . (nms)
2018-06-06
1
No Actions
REDACTED VERSION of 274 Reply Brief, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 6/7/2018 (nms). (Entered: 06/07/2018)
2018-06-07
1
REDACTED VERSION of 275 Declaration, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibits A-D)(Golden, Ronald) Modified on 6/7/2018 (nms). (Entered: 06/07/2018)
2018-06-07
1
REDACTED VERSION of 276 Reply Brief, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) Modified on 6/7/2018 (nms). (Entered: 06/07/2018)
2018-06-07
1
REDACTED VERSION of 277 Declaration, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibits 1-6)(Golden, Ronald) Modified on 6/7/2018 (nms). (Entered: 06/07/2018)
2018-06-07
1
REDACTED VERSION of 290 Letter, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A-B)(Golden, Ronald) (Entered: 06/07/2018)
2018-06-07
1
SECOND REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 281 . (nms)
2018-06-08
1
No Actions
REDACTED VERSION of 281 Letter by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 1)(Hufnal, AnnaMartina) (Entered: 06/12/2018)
2018-06-12
1
Letter to Honorable Richard G. Andrews, from Kelly Allenspach Del Dotto, regarding errata of corrections to trial transcript. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Del Dotto, Kelly) Modified on 6/21/2018 (nms). (Entered: 06/20/2018)
2018-06-20
1
Letter to Honorable Richard G. Andrews from Kelly Allenspach Del Dotto regarding errata to trial transcripts. (Attachments: # 1 Exhibit A)(Del Dotto, Kelly) (Entered: 06/22/2018)
2018-06-22
1
POST-TRIAL Opening Brief on Infringement, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
POST-TRIAL Answering Brief on Non-Infringement, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
POST-TRIAL Opening Brief on Invalidity, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
POST-TRIAL Opening Brief on Patent Exhaustion and Implied License, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
POST-TRIAL Answering Brief on Patent Exhaustion and Implied License, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
POST-TRIAL Answering Brief on Invalidity, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
POST-TRIAL Reply Brief on Invalidity, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
POST-TRIAL Reply Brief on Patent Exhaustion and Implied License, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
Proposed Findings of Fact Regarding Invalidity, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
Proposed Findings of Fact Regarding Exhaustion and Implied License, by Merck Sharp & Dohme Corp.. (Connolly, Arthur) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
POST-TRIAL Reply Brief on Infringement, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
Findings of Fact and Conclusions of Law on Infringement, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Hufnal, AnnaMartina) Modified on 6/25/2018 (nms). (Entered: 06/22/2018)
2018-06-22
1
Letter to The Honorable Richard G. Andrews from Martina Tyreus Hufnal regarding status of e-briefs. (Hufnal, AnnaMartina) (Entered: 06/28/2018)
2018-06-28
1
Official Transcript of Bench Trial (Day 1) held on 05-29-18 before Judge r. Court Reporter/Transcriber Leonard A. Dibbs/Valerie Gunning. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/26/2018. Redacted Transcript Deadline set for 8/6/2018. Release of Transcript Restriction set for 10/3/2018. (lad) (Entered: 07/05/2018)
2018-07-05
1
Official Transcript of Bench Trial (Day 2) held on 05-30-18 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs/Valerie Gunning. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/26/2018. Redacted Transcript Deadline set for 8/6/2018. Release of Transcript Restriction set for 10/3/2018. (lad) (Entered: 07/05/2018)
2018-07-05
1
Official Transcript of Bench Trial (Day 3) held on 05-31-18 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs/Valerie Gunning. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/26/2018. Redacted Transcript Deadline set for 8/6/2018. Release of Transcript Restriction set for 10/3/2018. (lad) (Entered: 07/05/2018)
2018-07-05
1
Official Transcript of Bench Trial (Day 4) held on 06-01-18 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs/Valerie Gunning. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/26/2018. Redacted Transcript Deadline set for 8/6/2018. Release of Transcript Restriction set for 10/3/2018. (lad) (Entered: 07/05/2018)
2018-07-05
1
Official Transcript of Bench Trial (Day 5) held on 06-04-18 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs/Valerie Gunning. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/26/2018. Redacted Transcript Deadline set for 8/6/2018. Release of Transcript Restriction set for 10/3/2018. (lad) (Entered: 07/05/2018)
2018-07-05
1
Letter to Honorable Richard G. Andrews from Ronald P. Golden III regarding status of ebrief. (Golden, Ronald) (Entered: 07/06/2018)
2018-07-06
1
Letter to Honorable Richard G. Andrews from Ronald P. Golden regarding ebriefs. (Golden, Ronald) (Entered: 07/09/2018)
2018-07-09
1
Joint Trial Transcript Errata, by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Del Dotto, Kelly) Modified on 7/23/2018 (nms). (Entered: 07/20/2018)
2018-07-20
1
MOTION for Pro Hac Vice Appearance of Attorney Stephanie Lollo Donahue - filed by Sanofi Winthrop Industrie, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Golden, Ronald) (Entered: 07/24/2018)
2018-07-24
1
SO ORDERED, re 330 MOTION for Pro Hac Vice Appearance of Attorney Stephanie Lollo Donahue, filed by Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 7/24/2018. (nms)
2018-07-24
1
No Actions
Pro Hac Vice Attorney Stephanie L. Donahue for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
2018-07-25
1
No Actions
Letter to The Honorable Richard G. Andrews, from Ronald P. Golden III, regarding update on Inter Partes Review. (Golden, Ronald) Modified on 9/14/2018 (nms). (Entered: 09/13/2018)
2018-09-13
1
[SEALED] NOTICE of Subsequent Events, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibits 1-3, # 2 Certificate of Service)(Connolly, Arthur) Modified on 10/12/2018 (nms). (Entered: 10/12/2018)
2018-10-12
1
[SEALED] MOTION to Dismiss - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibit 1-3, # 2 Proposed Order, # 3 Certificate of Service)(Connolly, Arthur) Modified on 10/12/2018 (nms). (Entered: 10/12/2018)
2018-10-12
1
Set Answering Brief Deadline re 333 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter. Answering Brief/Response due date per Local Rules is 10/26/2018. (nms)
2018-10-12
1
No Actions
REDACTED VERSION of 332 Notice of Subsequent Events, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibits 1-3)(Akhimien, Mary) Modified on 10/22/2018 (nms). (Entered: 10/19/2018)
2018-10-19
1
REDACTED VERSION of 333 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibits 1-3, # 2 Proposed Order)(Akhimien, Mary) (Entered: 10/19/2018)
2018-10-19
1
[SEALED] STIPULATION of Dismissal by Merck Sharp & Dohme Corp.. (Akhimien, Mary) (Entered: 10/26/2018)
2018-10-26
1
CERTIFICATE OF SERVICE for Joint Stipulation and Order of Dismissal by Merck Sharp & Dohme Corp. (D.I. 336 ). (Akhimien, Mary) Modified on 10/29/2018 (nms). (Entered: 10/26/2018)
2018-10-26
1
[SEALED] ORDER Granting 336 Joint Stipulation and Order of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 10/29/2018.This order has been emailed to local counsel. (nms) (Entered: 10/29/2018)
2018-10-29
1
REDACTED VERSION of 336 Stipulation of Dismissal by Merck Sharp & Dohme Corp.. (Akhimien, Mary) (Entered: 11/01/2018)
2018-11-01
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,918,833; US 8,512,297; US 8,556,864; US 8,603,044; US 8,992,486; US 8,679,069; US 9,011,391; US 9,233,211; US 7,476,652; US 7,713,930; US 8,603,044; US 9,457,152; US 9,486, 587; US 9,526, 844; US 9,533, 105; US 9,592,348; US 9,604,008. (Attachments: # 1 Redacted Order (original sealed order found at D.I. 338))(nms) (Entered: 11/05/2018)
2018-11-05
1
Letter to Counsel, dated 12/14/2018, from the Court, regarding the return of trial exhibits (see D.I. 300 Exhibit List). (nms) (Entered: 12/14/2018)
2018-12-14
1
ACKNOWLEDGMENT OF RECEIPT of Plaintiffs' exhibits and the joint exhibits for the trial held on May 29, 2018, through June 4, 2018. (nms) (Entered: 01/09/2019)
2019-01-09
1
ACKNOWLEDGMENT OF RECEIPT of Defendant's exhibits for the trial held on May 29, 2018m through June 4, 2018. (nms) (Entered: 01/09/2019)
2019-01-09
1